A report out of the oval office today has indicated Hydroxychloroquine has limited or no effectiveness in combating COVID-19 in a one-president study.
Hard Money will continue to report on this story as it unfolds and its impact on the markets. But at press time, Hydroxychloroquine futures had plummeted.